Lorenzo has a notable expertise in life sciences & healthcare, providing assistance since several years to leading operators in this area (including hospitals and other healthcare facilities, diagnostic centers, pharmaceutical companies, manufacturers and distributors of medical devices, universities, Scientific Institutes of Hospitalisation and Care (IRCCS) and foundations).
He mainly deals with M&A transactions and regulatory matters, as well as on all corporate, civil, commercial and compliance issues related to the hospital, pharmaceutical, medical devices, scientific research, artificial intelligence, digital health, veterinary and animal care sectors. He also advises on authorisation and accreditation procedures.
In recent years, he has been involved also in major M&A transactions between leading players in the healthcare and insurance sectors, contributing to the introduction of new business models in the Italian market, as well as in some of the first projects applying artificial intelligence to the healthcare sector for the development of highly innovative solutions.
He assists national and international clients in M&A transactions and in corporate and commercial law matters across other industries, and he has also gained significant experience in civil and commercial litigation and in restructuring.
He lectures at Università Vita-Salute San Raffaele (Milan).
The Legal 500 mentions Lorenzo in the Healthcare and Life Sciences section as follows: “Lorenzo Gentiloni Silveri is a true leader in the field and a great professional. His dedication and attention to the client are incomparable”, “He is an outstanding lawyer, complete in his preparation, curious about new challenges” (2025), “Lorenzo Gentiloni Silveri is an outstanding lawyer with a wide range of abilities. His work is always done very quickly but is always precise” (2023), “He is outstanding for competence, timeliness and dedication, as well as for flexibility in adapting the approach to the specific needs of the client by providing advice that is strategically valuable”, “I work closely with Lorenzo Gentiloni and am very satisfied with the work produced by him and his team” (2022).
